Pre/pro-B cells generate macrophage populations during homeostasis and inflammation by Audzevich, T et al.
Supplementary Figure 1.1 
Supplementary Figure 1.1. Gating strategies for flow cytometric identifications of tissue-
resident Mφs. a, Tissue-resident Mφs were discriminated from cell debris by size (FSC) and 
granularity (SSC), followed by cell doublets exclusion using Height (FSC-H/SCC-H), Width 
(FSC-W) and Area (SCC-A) parameters, and then identified within live cell gate as CD11b++
(brain and liver) or as CD11b++F4/80++(intestine) cells within CD45+CD19- population. Splenic 
Mφs were identified as CD3-CD19-MHC-II+ cells, which were CD11b+CD11c-(R3) and F4/80+(not 
shown), while peritoneal and pleural cavity Mφs were CD19-CD11c-CD11b++F4/80++. 
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Supplementary Figure 1.2 Analysis of Mb1-iCre/Rosa26-YFP mice for YFP expression within cells 
of various organs including (a) peripheral blood B and T cells as well as monocytes and neutrophils. 
Analysis of (b) bone marrow hematopoietic precursors revealed some YFP expression in uncommitted 
common lymphoid progenitors (CLP) only while (c) shows YFP expression in thymus. 
 
 
Supplementary Figure 1.3  
Supplementary Figure 1.3. Gating strategies for flow cytometric identification of 
peripheral blood cell populations. a, Blood cells were discriminated from cell debris by size 
(FSC) and granularity (SSC), followed by cell doublets exclusion using Height (FSC-H/SCC-H), 
Width (FSC-W) and Area(SCC-A) parameters. B cells were identified within B220+CD19+ gate, 
T cells as CD3+ within B220-CD19- gate, while neutrophils were CD115-Gr1++  and monocytes 
were CD115+Gr1+/- cells within B220-CD19-CD3- gate.  
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Supplementary Figure 1.4. Gating strategies for flow cytometric identification of 
hematopoietic progenitors in bone marrow and T cell progenitors in thymus. a, Bone 
marrow/thymus  cells were discriminated from cell debris by size (FSC) and granularity (SSC), 
followed by cell doublets exclusion using Height (FSC-H/SCC-H), Width (FSC-W/SCC-W) 
parameters. b, Sca-1++c-Kit++ multi-lineage progenitors (MLP) and Sca-1+c-Kit+ common 
lymphoid progenitors (CLP) were identified within Lin-IL7Rα- and Lin-IL7Rα+ bone marrow 
fractions respectively. c, Sca-1-c-Kit++ total myeloid progenitors (MP) were identified within Lin-
IL7Rα- bone marrow fraction and were comprised of three populations: CD34+/-CD16/32+ 
common myeloid progenitor (CMP), CD34+CD16/32++ granulocyte/macrophage progenitor 
(GMP) and CD34-CD16/32- megakaryocyte/erythrocyte progenitor. d, CD4-CD8- (DN) Early 
Thymic progenitors (ETP) were identified within Lin- fraction of thymic cells, while immature 
thymocytes CD4+CD8+ and mature T cells were either CD4+ or CD8+. Lin  markers for MLPs and 
CLPs included CD3, CD4, CD8, B220, CD11b, Gr1, TER119; for MPs - CD3, CD4, CD8, CD19, 
B220, IgM, CD11b, Gr1, TER119; for ETPs - CD19, B220, CD11b, Gr1, NK1.1, TER119.  
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Supplementary Figure  2. Phagocytosis of YFP+ B cells by Mφs does not result in 
generation of YFP+ Mφs. a, Immunoﬂuorescent	   microscopy	   on	   FACS-­‐puriﬁed	   peritoneal	   cell	  
popula9ons.	   b, Flow cytometric analysis of splenic YFP+ CD19+ B cells following FACS-
purification was carried out immediately after purification and at 5 and 20 hours after culturing in 
RPMI media supplemented with 5 % FBS, 1000 U/ml penicillin, 1000 µg/ml streptomycin and 2 
mM L-glutamine. Upon culturing without stimulation splenic B cells spontaneously undergo 
apoptosis as determined by Annexin V and 7-AAD staining. Importantly, after 20 hours the loss 
of the YFP signal from FACS-purified YFP+CD19+ splenic B cells correlated with low forward 
scatter and double labelling for Annexin V and 7-AAD, which are characteristic of advanced 
apoptosis. c, Dot-plots showing CD11b++F4/80++ Mφ pre-sort populations in peritoneal washout: 
YFP+ Mφs (green), YFP- Mφs (red) and very few events showing as YFP low (blue); post-sort 
purity assessment of YFP- and YFP+ Mφs. FACS-purified peritoneal YFP- Mφs were co-
incubated with 5 or 20 hours-aged splenic YFP+CD19+ B cells for 1 hour and phagocytosis was 
analysed by (d) microscopy where nuclei were visualized by DAPI in blue, α-F4/80 staining in 
red and α-GFP(YFP) staining highlights YFP+ B cells and YFP+ Mφs in green. Yellow arrow 
heads highlight phagocytised B cells, as determined by dense DAPI labelling of apoptotic B cell 
nuclei contrasting with larger Mφ nuclei revealing condensed and relaxed chromatin structures. 
e, Flow cytometric analysis following co-culturing of YFP- Mφs with aged splenic B cells 
revealed only a minor population of Mφs (in blue gate) with increased YFP signal. Histogram 
showing YFP signal expressed as mean fluorescence intensity (MFI) confirms that population of 
YFP- Mφs that have phagocytised YFP+ B cells doesn’t gain YFP signal comparable to YFP 
signal detected in YFP+ Mφs of Mb1-iCre/Rosa26-YFP mice. 
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Supplementary Figure 3.1 ImageStream analysis of peritoneal bi-phenotypic YFP+CD19+ 
Mφs in Mb1-iCre/Rosa26-YFP mice. a, Single cells were discriminated from doublets by 
Aspect ratio and Area parameters. Mφs were identified as CD11b++F4/80++ cells (Mac) within 
single focused cell gate while  B cells are YFP+CD19+ population within non-Mφ gate. b, Dot 
plot showing increased frequency of YFP+CD19+ population in the CD11b++F4/80++ Mφ gate, 
when gated on focused doublets. c, Representative images of cell populations gated as above 
confirming CD19 expression on a sub-population of YFP+ Mφs, but showing that Aspect ratio 
and Area parameters do not allow to exclude all cell clusters and specifically those  that have 
width to heights ratio close to 1, as shown for YFP+CD19+ Mφ population clusters in singlets 
gate.  
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Supplementary Figure 4.1 Gating strategy for flow cytometric identification of B cell 
development stages in bone marrow. a, Bone marrow cells were discriminated from cell 
debris by size (FSC) and granularity (SSC), followed by cell doublets exclusion using Heights 
(FSC-H/SCC-H), Width (FSC-W/SCC-W) parameters. Early B220+CD43+ and late B220+CD43- 
B cell development stages were identified within CD11b-CD3- gate. Early B cells were separated 
into fractions A, B, C and C’ using CD24/HSA and PB-1/Ly-51 antigens: with fraction A being 
pre-pro-B cells, fraction B and C – pro-B cells and fraction C’ – pre-B cells. B220+CD43- B cells 
comprised of fractions D (pro-B), E (new-B) and F (mature B) discriminated by IgM and IgD 
expression. b, Despite CD19 being expressed on the majority of fraction B/pro-B cells, YFP 
levels in this early B cell subset of CD19-Cre/Rosa26-YFP mice (CD19-Cre) are very low 
compared to those detected in Mb1-iCre/Rosa26-YFP mice (Mb1-iCre). 
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Supplementary Figure 4.2 High CD16/32 and CD11b expression intrinsic to myeloid cells. 
a,  Flow cytometry analysis of bone marrow and peripheral blood cell populations revealed high 
levels of CD16/32 and CD11b on myeloid cells: Gr1++CD115- granulocytes and Gr1+CD115+ 
monocytes in contrast to B220+CD19+ B cells.    
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Supplementary Figure 4.3 Cell surface characteristics of bi-phenotypic pB-Mφprecursors in 
naïve bone marrow and blood. Cells and tissues from Mb1-iCre/Rosa26-YFP mice were 
collected and analysed by flow cytometry. a, Bi-phenotypic pB-Mφprecursors with B cell and 
myeloid characteristics namely CD19+B220+CD43+YFP+CD16/32++CD11b+ were identified in 
bone marrow and blood. b, Expression pattern of selected cell surface markers on pB-
Mφprecursors from naive bone marrow and blood with c showing the expression on IL7Ra during 
the early phases of B cell development. 
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Supplementary Figure 5.2. Morphological changes  in pB-Mφprecursors and Mφs during in 
vitro cell culturing. FACS-purified Mφs, peritoneal B cells and peritoneal pB-Mφprecursors from 4 
hour peritonitis were cultured on poly-L-lysine-coated coverslips with/without M-CSF for 1, 3, 
and 6 days. a, Rapid-Romanowsky stain revealed typical morphology of B cells for pB-
Mφprecursors characterized by high nuclear-cytoplasmic ratio and small cell size, while elongated/
spindle-shaped Mφs had significantly lower nuclear-cytoplasmic ratio and greater cell size at 
day 1. Upon culturing  in presence of 10ng/ml  M-CSF majority of pB-Mφprecursors acquired 
morphology characteristic for Mφs, while B cells and pB-Mφprecursors without M-CSF remained  
small and round cells. Scale bars, 20 µm. 
Supplementary Figure 6.1 
Supplementary Figure 6.1. Gating strategy for isolation of early pro-B and mature B cells from 
bone marrow of Mb1-iCre/Rosa26R-YFP mice. Mature B cells (YFP+B220highCD19+CD43-CD24low) and 
early pro-B /Fr. B cells (YFP+B220+CD19+CD43+CD24+BP-1-) from bone marrow of Mb1-iCre/Rosa26-
YFP mice were FACS-purified as shown and injected into lethally irradiated mice to trace the 
reconstitution of tissue Mφ populations by bi-phenotypic YFP+CD16/32++CD11b++ pB-Mφprecursors within 
early pro-B cell fraction.  
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Supplementary Figure 6.2. YFP+CD16/32++CD11b pB-Mφprecursors within early pro-B cell bone marrow 
fraction reconstitute peritoneal Mφs in lethally irradiated mice. Gating strategies identifying lymphoid 
and myeloid cell populations in (A) peritoneum and (B) spleen. FACS-purified early pro-B cells containing a 
bi-phenotypic pB-Mφprecursors and mature B cells (control) from bone marrow of Mb1-iCre/Rosa26-YFP mice 
(see suppl. Fig. 6.1) were mixed in ratio 1:10 with total bone marrow cells from congenic CD45.1 donor mice 
and injected i.v. into lethally irradiated (9.5 Gy) wild type mice. Haematopoietic reconstitution was assessed 
in peritoneum and spleen at 2 and 4 weeks post injection of donor bone marrow cells. (C) Representative 
plots showing engraftment of donor CD45.1+ (all lineages) and YFP+ (early pro-B/mature B) cells in the 
peritoneum of lethally irradiated mice at 2 and 4 weeks post adoptive cell transfer.  
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Supplementary Figure 7.1. PKH-Red labelling distinguishes between resident and inflammation-
induced populations of peritoneal Mφs. To label resident peritoneal Mφs in contrast to infiltrating monocytes 
and inflammation-induced Mφs, phagocytic dye PKH-Red was injected i.p. 2 hours prior to zymosan 
administration. a, Gating strategy for identification of peritoneal  Mφs. b, Peritoneal and peripheral blood 
leukocyte populations were analysed by flow cytometry. CD11b++F4/80++ peritoneal Mφs revealed bright and 
homogenous labelling after 2 hours post PKH-Red injection being a result of phagocytic ingestion of the dye, 
while no CD3-CD19-Gr1-/+CD115+ blood monocytes were labelled by PKH-Red at any time. Animals that 
received PKH-Red and zymosan (PKH + Zym) i.p. revealed PKH-Red+ (resident) and PKH-Red- (inflammation-
induced/monocyte-derived) populations within CD11b++F4/80++ Mφ gate. c-d, Due to their phagocytic ability 
CD19+ B cells acquire some PKH-Red signal, which is however significantly lower than PKH-Red labelling of 
resident Mφs (b, c), including YFP+ Mφs present in naïve cavity and at 72 hours (d). This allows discrimination 
between PKH+ pB-Mφs present in naïve peritoneum and PKH-/low pB-Mφsinflam triggered from pro-B cells (PKH-
Red-/low) by inflammation detected by 72 hours of zymosan peritonitis in Mb-1.iCre/Rosa26-YFP mice (d).  
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Supplementary Figure 7.2. Gating strategy for isolation of Mφ and B cell sub-sets from 
Mb1-iCre/Rosa26R-YFP mice and post-sort purity assessment.  a,  CD19+ B cells and 
CD11bhighF4/80high peritoneal Mφs identified among live single cells demonstrate YFP, F4/80 
and CD11b expression levels characteristic for each cell type, i.e. high YFP, low/no F4/80 and 
no/intermediate CD11b expression on B cells; high F4/80 and CD11b on all Mφs with fraction of 
Mφ population expressing YFP. b-c,  Gating strategies for FACS-purification of peritoneal Mφ 
populations and B cells from naïve  peritoneum (b) and peritoneum at 72 hours post zymosan 
peritonitis induction (c). d, Mφ populations (n=3 per group) used for transcriptomic analysis 
were subjected to post-sort purity assessment. The content of contaminating B cells (YFP
+CD19+) in FACS-purified Mφ samples, expressed in % from total Mφ sample. 
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Supplementary Figure 7.3. Low variability across biological replicates of transcriptomic 
samlpes. Probe labelling and hybridization were performed using an Illumina Mus musculus 
6v2 microarray (n=3 biological replicates). Array probe summaries were calculated in 
BeadStudio (Illumina) and subsequently normalized by a variance stabilising transformation 
(VST) and robust spline normalisation (RSN) using the lumi R/BioConductor package. a-b, Box 
plots of un-normalized (a) and normalized (b) expression data showing low variation within each 
sample group (n=3). 
Supplementary Figure 7.4 
a 
e 
c 
f 
Monocyte and Neutrophil clusters  
Inflammatory Mφ clusters  
Cell cycle cluster  
MHC class II cluster  
Tissue-resident Mφ cluster  
Ribosome/Transcription clusters 
Selected genes 
M
ea
n 
ex
pr
es
si
on
 
0 
1000 
2000 
B
-2
 B
 c
el
ls
 
B
-1
 B
 c
el
ls
 
M
on
oc
yt
es
 
M
φ
TR
-n
aï
ve
  
M
φ
TR
-in
fla
m
 
m
o-
M
φ
in
fla
m
 
pB
-M
φ
TR
-n
aï
ve
  
pB
-M
φ
TR
-in
fla
m
 
pB
-M
φ
in
fla
m
  
N
eu
tr
op
hi
ls
 1  2  3      1  2   3     1   2   3     1   2   3     1   2   3     1   2   3    1   2   3     1   2   3     1   2   3     1   2   3     
M
ea
n 
ex
pr
es
si
on
 
0 
1000 
2000 
  C55.  
  C71.  
B
-2
 B
 c
el
ls
 
B
-1
 B
 c
el
ls
 
M
on
oc
yt
es
 
M
φ
TR
-n
aï
ve
  
M
φ
TR
-in
fla
m
 
m
o-
M
φ
in
fla
m
 
pB
-M
φ
TR
-n
aï
ve
  
pB
-M
φ
TR
-in
fla
m
 
pB
-M
φ
in
fla
m
  
N
eu
tr
op
hi
ls
 1  2  3      1  2   3     1   2   3     1   2  3     1   2   3     1   2   3    1   2   3     1   2   3     1   2   3     1   2   3     
  C7.  
  C1.  
  C16.  
M
ea
n 
ex
pr
es
si
on
 
0 
200 
400 
B
-2
 B
 c
el
ls
 
B
-1
 B
 c
el
ls
 
M
on
oc
yt
es
 
M
φ
TR
-n
aï
ve
  
M
φ
TR
-in
fla
m
 
m
o-
M
φ
in
fla
m
 
pB
-M
φ
TR
-n
aï
ve
  
pB
-M
φ
TR
-in
fla
m
 
pB
-M
φ
in
fla
m
  
N
eu
tr
op
hi
ls
 1  2  3      1  2   3     1   2   3     1   2   3     1   2   3     1   2   3    1   2   3     1   2   3     1   2   3     1   2   3     
g 
M
ea
n 
ex
pr
es
si
on
 
0 
5000 
15000 
B
-2
 B
 c
el
ls
 
B
-1
 B
 c
el
ls
 
M
on
oc
yt
es
 
M
φ
TR
-n
aï
ve
  
M
φ
TR
-in
fla
m
 
m
o-
M
φ
in
fla
m
 
pB
-M
φ
TR
-n
aï
ve
  
pB
-M
φ
TR
-in
fla
m
 
pB
-M
φ
in
fla
m
  
N
eu
tr
op
hi
ls
 1  2  3      1  2   3     1   2   3     1   2   3     1   2   3     1   2   3    1   2   3     1   2   3     1   2   3     1   2   3     
10000 
  Ccl2 
Csf3r 
M
ea
n 
ex
pr
es
si
on
 
0 
500 
1500 
B
-2
 B
 c
el
ls
 
B
-1
 B
 c
el
ls
 
M
on
oc
yt
es
 
M
φ
TR
-n
aï
ve
  
M
φ
TR
-in
fla
m
 
m
o-
M
φ
in
fla
m
 
pB
-M
φ
TR
-n
aï
ve
  
pB
-M
φ
TR
-in
fla
m
 
pB
-M
φ
in
fla
m
  
N
eu
tr
op
hi
ls
 1  2  3      1  2   3     1   2   3     1   2  3     1   2   3     1   2   3    1   2   3     1   2   3     1   2   3     1   2   3     
1000 
  C20.  
  C24.  
  C40.  
  C34.  
  C72.  
  C6.  
d 
M
ea
n 
ex
pr
es
si
on
 
0 
10000 
20000 
B
-2
 B
 c
el
ls
 
B
-1
 B
 c
el
ls
 
M
on
oc
yt
es
 
M
φ
TR
-n
aï
ve
  
M
φ
TR
-in
fla
m
 
m
o-
M
φ
in
fla
m
 
pB
-M
φ
TR
-n
aï
ve
  
pB
-M
φ
TR
-in
fla
m
 
pB
-M
φ
in
fla
m
  
N
eu
tr
op
hi
ls
 1  2  3      1  2   3     1   2   3     1   2   3     1   2   3     1   2   3    1   2   3     1   2   3     1   2   3     1   2   3     
b 
G
en
e 
ex
pr
es
si
on
 
0 
500 
1500 
B
-2
 B
 c
el
ls
 
B
-1
 B
 c
el
ls
 
M
on
oc
yt
es
 
M
φ
TR
-n
aï
ve
  
M
φ
TR
-in
fla
m
 
m
o-
M
φ
in
fla
m
 
pB
-M
φ
TR
-n
aï
ve
  
pB
-M
φ
TR
-in
fla
m
 
pB
-M
φ
in
fla
m
  
N
eu
tr
op
hi
ls
 1  2  3      1  2   3     1   2   3     1   2   3     1   2   3     1   2   3    1   2   3     1   2   3     1   2   3     1   2   3     
1000 
B cells 
Monocytes 
Embryonic/monocyte-derived Mφs 
Pro-B cell-derived Mφs 
Neutrophils 
Supplementary Figure 7.4. Transcriptome analysis of pro-B cell-derived Mφs: expression 
profile of selected genes and gene clusters. The software tool Biolayout Express3D was used 
for the visualization and analysis of Illumina Mus musculus 6v2 microarray data, which were 
variance stabilized (VST) and robust spline normalized (RSN) using the lumi R/BioConductor 
package. Full probeset-to-probeset Pearson correlation matrix was calculated in Biolayout 
Express3D for each transcript represented on the array across the 30 samples using a 
correlation threshold of r ≥ 0.95; MCL clustering algorithm with inflation value of 1.7 was used to 
generate gene clusters with similar functions or cell-specific activities. Expression profile of 
selected genes (b) or gene clusters (a, c-g) across all samples showing expression levels in 
pro-B cell-derived Mφs (blue rectangle) and embryonic/monocyte-derived Mφs (red rectangle). 
Mean expression levels of probe sets in monocyte-related cluster C7 and Neutrophil-related 
cluster C1 (a); Gene expression level of selected monocyte-related gene Ccl2 and neutrophil-
related Csf3r gene (b). Mean expression profiles of genes within cell-cycle-related gene cluster 
C16. (c); ribosomal and transcription-related gene clusters C20 and C24 (d) expressed highly 
by almost all cell populations except neutrophils; cluster C72 containing MHC class II genes 
expressed highly by B cells and both populations of inflammation-induced Mφs (pB-Mφinflam/
mo-Mφinflam) (e).	   Genes highly expressed in inflammation-induced Mφs (pB-Mφinflam/mo-
Mφinflam) in comparison to the other macrophage populations were found in clusters C55 and 
C71 (f), while clusters C6, C36 and C40 included genes characteristically expressed by tissue-
resident Mφs from naïve (pB-MφTR-naïve/MφTR-naïve) and inflamed (pB-MφTR-inflam/MφTR-inflam) 
peritoneum (g). 
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Expression profile of selected genes or gene clusters across all 30 datasets plotted in a-c  
showing expression levels for pro-B cell-derived Mφs (blue rectangle) and embryonic/monocyte-derived 
 Mφs (red rectangle). Mean expression levels of probe sets in B cell-related clusters C2. and C4. (a) and 
 Monocyte/Mφ-related clusters C5. C17, C50 (c); Gene expression level of selected B cell-related genes 
 IgH-V11, Sox5 and Cd19 (b) and Monocyte/Mφ-related genes Csf1r and Lyz1 (d). No clusters were  
identified, which contained genes which were expressed highly in pro-B cell-derived Mφs alone.  
 
Supplementary Figure 7.5 
Supplementary data, Table S1 
 
1) Spleen 
 
 Day 7 
% CD45.2 
 
% eYFP in CD45.2 
Day 14 
% CD45.2 
 
%eYFP in CD45.2 
CD4 T cells 0.18 ± 0.14 0 5.03 ± 0.90 0 
CD8 T cells 0.15 ± 0.08 0 2.59 ± 0.79 0 
γδ T cells 0.12 ± 0.22 0 0.63 ± 0.31 0 
NK cells 4.91 ± 3.12 0.80 ± 0.83 4.28 ± 2.01 0.38 ± 0.33 
imm. B cells 29.94 ± 5.81 28.78 ± 4.57 13.95 ± 3.27 13.46 ± 2.84 
T1 B cells 5.86 ± 1.46 5.59 ± 1.75 18.68 ± 3.68 18.21 ± 3.87 
T2 B cells 2.98 ± 1.11 2.71 ± 1.13 7.56 ± 1.09 7.45 ± 1.46 
T3 B cells 0.77 ± 0.53 0.57 ± 0.36 8.92 ± 0.92 8.20 ± 0.60 
Myeloid cells 49.35 ± 5.30 1.51 ± 0.45 17.33 ± 7.71 0.97 ± 0.55 
Dendritic cells 2.39 ± 1.24 4.81 ± 9.83 2.41 ± 1.47 0.29 ± 0.17 
 
2) Thymus 
 
 Day 7 
% CD45.2 
 
% eYFP in CD45.2 
Day 14 
% CD45.2 
 
%eYFP in CD45.2 
ETP 64.88 ± 4.94 0.32 ± 0.11 2.15 ± 0.80 0.32 ± .023 
DN2 11.17 ± 2.15 0.04 ± 0.09 6.62 ± 2.4 0.04 ± 0.03 
DN3 4.29 ± 1.78 0 22.70 ± 8.63 0 
DN4 1.00 ± 0.83 0 2.12 ± 0.68 0 
DP 0.65 ± 0.75 0 48.24 ± 7.46 0 
SP CD4 0.13 ± 0.17 0 4.54 ± 0.92 0 
SP CD8 1.10± 0.71 0.62 ± 1.34 1.86 ± 0.57 0 
γδ T cells 2.57 ± 1.10 0.02 ± 0.01 0.36 ± 0.06 0.01 ± 0.01 
Dendritic cells 0.06 ± 0.08 0.01 ± 0.02 0.08 ± 0.06 0 
 
3) Bone Marrow 
 
 Day 7 
% CD45.2 
 
% eYFP in CD45.2 
Day 14 
% CD45.2 
 
%eYFP in CD45.2 
pro B cells 34.08 ± 4.71 33.70 ± 4.7 8.92 ± 3.78 8.64 ± 3.41 
pre B cells 18.41 ± 5.48 18.47 ± 6.0 21.35 ± 9.71 20.94 ± 8.47 
imm. B cells 8.40 ± 6.01 8.15 ± 5.47 8.58 ± 2.63 8.70 ± 2.58 
mat. B cells 0.75 ± 0.94 0.79 ± 0.64 4.23 ± 0.30 4.19 ± 0.31 
CLP 1.99 ± 1.31 0.28 ± 0.30 0.22 ± 0.32 0.05 ± 0.04 
Myeloid cells 31.25 ± 12.09 1.62 ± 1.11 3.59 ± 2.52 0.19 ± 0.08 
 
 
Transfer of 2 x 103 LMPP (B6.Mb1iCre/Gtrosa26eYFP) into CD45.1 Rag2-null (0.5 Gy irradiated) i.v. 
Supplementary Materials and Methods 
 
BCR re-arrangements detection and single cell PCR and RT-PCR 
Sample preparation: FACS-purified single, 5, 10 or 20 cells were collected into 
wells of 96-well plates containing either 20 µl of lysis buffer A (1x DreamTaqTM DNA 
Polymerase Buffer (Thermo Scientific), 0.01% Gelatin (Sigma)) for PCR on genomic 
IgH locus; or 20 µl of lysis buffer B (1.25x of M-MVL Reverse Transcriptase Reaction 
Buffer (Promega), 0.4 units/µl of RNasin (Promega), 0.3125% Igepal (Sigma)) for 
reverse-transcription PCR and detection of B cell- and macrophage-specific mRNA 
transcripts. Plates were frozen on dry ice immediately after sort and stored at -80°C.  
 
BCR re-arrangements detection by PCR: A multiplex PCR system was designed 
to amplify rearranged IgH genes from murine genomic DNA using nested PCR 
approach. Plates containg cells in 20 µl of lysis buffer A were thawed and briefly 
spun before addition of 1 µl of Protainase K (Invitrogen) to a final concentration of 
400 µg/ml and then incubated in Thermocycler (TECHNE) for 60 min at 55°C, 
followed by 10 min incubation at 95°C. First PCR step was performed with 11 outer 
forward primers, each specific to a group of functional IgHV genes, and 2 outer 
reverse primers specific to IgHJ genes (supplied by Sigma) (Table 1), using 0.125 µM 
of each primer, 3 µl of DreamTaqTM Buffer (1x), 0.25 µl of DreamTaqTM DNA 
Polymerase (Thermo Scientific), 1 µl of dNTPs (200 mM), 1 µl of 25mM MgCl2 (2.5 
mM) and 10 µl of 5x PCR enhancer (0.54 M Betaine, 1.34 mM DTT, 1.34% DMSO 
and 11 µg/ml BSA) per 50µl reaction, using the following PCR conditions: 2 min at 
95oC, 30 cycles of 15 sec at 95oC, 30 sec at 59.5oC and 30 sec at 72oC, 10 min at 
72oC on an Techne Thermocycler.  
 
Table 1. Primer sequences used for IgH amplification (1st PCR amplification)   
Primer ID Primer sequence  Tann  
VH-for1 GAGGTTCDSCTGCAACAGTY 
Outer 
forward 
primers 
 
 
 
 
 
59.5 °C 
 
 
 
 
 
 
 
 
59.5 °C 
 
   1st PCR  
 
Product size 
 ~300-400 
bp 
 
 
VH-for2 CAGGTGCAAMTGMAGSAGTC 
VH-for3 GAVGTGMWGCTGGTGGAGTC 
VH-for5 GAKGTGCAGCTTCAGSAGTC 
VH-for7 CAGRTCCAACTGCAGCAGYC 
VH-for8 GAGGTGMAGCTASTTGAGWC 
VH-for11 CAGATKCAGCTTMAGGAGTC 
VH-for12 CAGGCTTATCTGCAGCAGTC 
VH-for13 CAGGTTCACCTACAACAGTC 
VH-for14 CAGGTGCAGCTTGTAGAGAC 
VH-for15 GARGTGMAGCTGKTGGAGAC 
JH-1_rev CTTACCTGAGGAGACGGTGA 
Outer 
reverse 
primers JH-2_rev CTTACCTGCAGAGACAGTGA 
 
Obtained PCR products were diluted 1:10 with H2O and 1 µl was used for the second 
PCR reaction with 12 inner forward primers and 3 inner reverse primers (0.25 µM), 
using 2.5 µl of DreamTaqTM Green Buffer (1x), 0.125 µl of DreamTaqTM Green DNA 
Polymerase (Thermo Scientific), 0.5 µl of dNTPs (200 mM), 0.5 µl of 25mM MgCl2 
(2.5 mM)  and 5 µl of 5x PCR enhancer (0.54 M Betaine, 1.34 mM DTT, 1.34% 
DMSO and 11 µg/ml BSA) per 25 µl reaction. PCR was performed using the 
following conditions: 2 min at 95oC, 30 cycles of 15 sec at 95oC, 30 sec at 59oC and 
30 sec at 72oC, 10 min at 72oC on TECHNE Thermocycler. PCR products were 
analysed on 2% Agarose gel.  
 
Table 1 (continued). Primer sequences used for IgH amplification (2nd PCR 
amplification)  
Primer ID Primer sequence  Tann  
Inner_VH-for1 GGTTCDSCTGCAACAGTYWG 
Inner forward 
primers 
59.0 °C 
2nd PCR  
 
Product size 
~280-300 bp 
Inner_VH-for2 GGTGCAAMTGMAGSAGTCWG 
Inner_VH-for3 GTGMWGCTGGTGGAGTCTGG 
Inner_VH-for5 GTGCAGCTTCAGSAGTCWGG 
Inner_VH-for5_2 GTGCAGCTTCAGSAGTCGRG 
Inner_VH-for7 CTGAGCTGGTGARRCCTGG 
Inner_VH-for8 GTGMAGCTASTTGAGWCTGG 
Inner_VH-for11 CAGATKCAGCTTMAGGAGTCW
GGA 
Inner_VH-for12 CTGAGCTGGTGAGGC 
Inner_VH-for13 GTTCACCTACAACAGTCTGG 
Inner_VH-for14 GTGCAGCTTGTAGAGACCG 
Inner_VH-for15 TGMAGCTGKTGGAGACWGGA 
Inner_JH-1_rev CCAGACATCGAAGTACCAGT 
Inner reverse 
primers 
Inner_JH-2_rev GCCTTGACCCCAGTAGTC 
Inner_JH-3_rev GACAGTGACCAGAGTCCCTT 
  
 
Detection of B cell- and Mφ-specific mRNA transcripts by RT-PCR: Plates 
containg cells in 20 µl of lysis buffer B were thawed, briefly, spun, incubated at 70°C 
for 5 min and then cooled on ice. Random primers and Oligo(dT)15 Primers were 
incubated at 70°C for 5 min and then cooled on ice   before use. Reverse trancription 
reaction was performed on single and multiple cells using 1 µl of 500ng/µl Random 
Primers (Promega), 1 µl of 500 ng/µl Oligo(dT)15 Primer (Promega), 2 µl of 10 mM 
dNTPs and 0.5 µl M-MLV Reverse Transcriptase per 25 µl reaction using the 
following conditions: 5 min at 25oC, 60 min at 40oC and 10 min at  75oC. PCR 
amplification was performed using 10 µl of cDNA, 0.625 µl of forward and reverse 
Emr1 or Cd79b-specific primers (0.25 µM) (see Table 2), 2.5 µl of DreamTaqTM 
Green Buffer (1x), 0.125 µl of DreamTaqTM Green DNA Polymerase (Thermo 
Scientific), 0.5 µl of dNTPs (200 mM) and 0.75 µl of DMSO (3%) per 25µl reaction 
using the following conditions: 2 min at 95oC, 49 cycles of 15 sec at 95oC, 20 sec at 
specified annealing temperature (see Table 2) and 30 sec at 72oC, 10 min at 72oC on 
Techne Thermocycler. PCR products were analysed on 4% Agarose gel. 
Using PCR methods described above the following cell populations from naïve 
peritoneum were examined: B-1 B cells (CD19+ CD23- CD11b+ Gr1- F4/80-) and B-2 
B cells (CD19+ CD23+ CD11b- F4/80- ), naïve  CD19+ and CD19- pro-B cell-derived 
macrophages (F4/80high CD11bhigh YFP+), as well as yolk sac macrophages (F4/80high 
CD11bhigh YFP-) purified from B6.Mb1-iCre/Rosa26-YFP. At least 45 wells containing 
either single or multiple cells per well were analyse for each cell type.   
Table 2. Primer sequences used for RT-PCR 
Primer ID Primer sequence Tann Product size, bp 
Emr1_for GGAAGCCTCGTTTACAGGTG 
56.4°C 150 
Emr1_rev GGATGTACAGATGGGGGATG 
Cd79b_for GCTTTTTGGCTGCAAACCT 
54.1°C 95 
Cd79b_rev GGTACCAGCAATGACAAGCA 
 
Microarray analysis 
RNA was extracted from FACS-purified murine peritoneal cells populations using 
RNAZol (Moleclular Research Center, Inc.) and normalised to equal mass. Cell 
surface markers and relevant gating strategies used for cell purification are shown in 
Table 3 below and Fig. S15. Probe labeling and hybridization were performed using 
an Illumina Mus musculus 6v2 microarray as per manufacturer’s instructions. The 
array probe summaries for 30 datasets (n=3 per group) were calculated in 
BeadStudio (Illumina) and subsequently normalised by a variance stabilising 
transformation (VST) (1) and robust spline normalisation (RSN) using the lumi 
R/BioConductor package (2) (Fig. S16). Significantly differentially expressed genes 
were identified using the limma R/BioConductor package (3) to generate linear 
models for normalized probe intensity data, applying multiple t-tests between groups 
of sample replicates and selecting probes which gave Benjamini-Hochberg adjusted 
P-values < 0.001. Genes with very low or no expression among all samples 
compared were filtered out based on P-detection-value (> 0.01). Correlation analysis 
of the gene expression profiles of the individual cell populations and identification of 
co-expression modules were performed in Biolayout Express3D (4). The global gene 
expression profiles of the individual cell populations were compared using Pearson 
correlation threshold of r ≥ 0.97 in order to analyse the similarity between samples. A 
full probeset-to-probeset Pearson correlation matrix was calculated in Biolayout 
Express3D for each transcript represented on the array across the 30 samples using a 
correlation threshold of r ≥ 0.95. The graph was clustered using the MCL algorithm 
with an inflation value of 1.7 to generate clusters of genes with similar cell-specific 
activities. The network graph contained 11,216 nodes (probe sets representing 
specific transcripts) and after MCL-clustering (1.7) generated 272 distinct clusters 
containing ≥ 6 probe sets. The graph’s structure is presented in Fig. 6C. The 
microarray data are publicly available in ArrayExpress, accession number: E-MTAB-
1878. 
 
 
 
 
Table 3. Cell surface markers used for cell sorting  
Cell type Sorting strategy Source  
Follicular B-2 B cells B220+ CD23high CD21low Spleen 
C
57
B
L6
 m
ic
e Peritoneal B-1 B cells  CD19+ CD23- CD11bint F4/80- Peritoneum 
Peritoneal B-2 B cells CD19+ CD11b- CD23+ F4/80- Peritonitis 4h 
Monocytes 16h CD19- CD115+ Gr1int Peritonitis 16h 
Neutrophils 16h CD19- CD115- Gr1high CD11b+ Peritonitis 16h 
Naïve B-1/Mφs CD19- F4/80high CD11bhigh YFP+ Peritoneum 
B
6.
M
b1
-iC
re
/ 
R
os
a2
6-
Y
FP
 m
ic
e 
 
MφTR-naïve  CD19- F4/80high CD11bhigh YFP- Peritoneum 
mo-Mφinflam CD19- F4/80high CD11bhigh YFP- PKH-
Red- 
Peritonitis 72h 
+ PKH-Red 
MφTR-inflam CD19- F4/80high CD11bhigh YFP- PKH-
Red+ 
pB-Mφinflam CD19- F4/80high CD11bhigh YFP+ PKH-
Red- 
pB-MφTR-inflam CD19- F4/80high CD11bhigh YFP+ PKH-
Red+ 
 
 
 
Hematopoietic cell isolation 
 
Peritoneal cells were obtained by lavage with 2 ml of PBS-based cell dissociation 
buffer (Invitrogen). Cells were centrifuged at 750 g for 4 min at 4⁰C and then red 
blood cells were depleted by incubation with 0.2 ml ACK lysing buffer (Lonza).  Lysis 
was stopped by addition 1 ml of 1% FCS 2 mM EDTA in PBS (FACS Buffer) and 
subsequent centrifugation. Cells were washed once more with 1 ml of FACS buffer 
and counted. Pleural cavity cells very harvested and processed similarly. Spleens 
were crushed between two glass slides in cold RPMI supplemented with 10% FSC 
and 100 units/ml of penicillin and 100 µg/ml of streptomycin (Invitrogen), obtained 
crude cell suspension was vigorously mixed by pipetting, passed through 70 µm cell 
strainer (BD Falcon) and centrifuged. Red blood cell lysis was performed as above 
using 4-5 ml of ACK buffer/spleen. Bone marrow cells were purified from femurs and 
tibiae, which were cleaned from surrounding muscle tissues, dipped in 70% ethanol 
for 0.5-1 min for disinfection. Then both ends of the bone were cut with scissors and 
the marrow flushed with 1% FCS 2 mM EDTA in PBS/RPMI using a syringe with a 
26G needle. Clusters within the marrow were disintegrated by vigorous pipetting. 
Red blood cells were lysed as above. Incubation with 10x volume of ACK lysing 
buffer (Lonza) was employed for peripheral blood cells purification, which was 
followed by washing with PBS and FACS Buffer. Small and large intestines were 
dissected from mice, washed of faecal content with cold HBSS and opened 
longitudinally. Tissue was then cut in 0.5 cm pieces and incubated twice in 5 ml of 
5% FCS, 2 mM EDTA, 1 mM DTT in HBSS for 20 min at 37⁰C on shaker (220 rpm) 
to remove epithelial cells. Then tissue was briefly washed with cold PBS and 
digested with 1.5 mg/ml Collagenase VIII (Sigma), 0.5 mg/ml DNase I (Sigma) and 1 
mg/ml Dispase II (Sigma) in Dulbecco’s PBS with Mg2+ and Ca2+ for 20 min at 37⁰C 
on shaker (220 rpm). After complete digestion cells were strained through 70 µm 
mesh and centrifuged. Cells were washed once more with 1% FCS 2 mM EDTA in 
PBS prior use. For brain and liver mononuclear cells analysis animals were perfused 
with 30 ml PBS via the left ventricle. Brain and liver were collected; tissues were 
sectioned and homogenized using a dounce homogenizer to obtain cell suspensions, 
which were filtered through 70 µm mesh and spun. Pellets were re-suspended in 5 
ml of 30% percoll, laid over 5 ml 70% percoll and centrifuged at 1000 g for 20 min at 
20ºC with low acceleration and no brake. Cells from interphase were collected using 
Pasteur pipette washed once in PBS and analysed by flow cytometry. 
 
Clonal assay 
S17 stromal cell lines were maintained in Iscove’s modified Dulbecco’s medium with 
20% (vol/vol) FCS, seeded into 96 well flat bottomed plates and were irradiated with 
30 Gy at 80% confluency. 24 h later, cells were washed and supplemented with 10% 
(vol/vol) FCS, 0.1 mM βmercaptoethanol and media containing growth factors for 
myeloid development (SCF [100ng/ml], Flt3L [5ng/ml], M-CSF [100ng/ml] and anti-
IL7 Ab [3µg/ml]) or lymphoid development (SCF, Flt3 and IL7 [10ng/ml]). Growth 
factors were from Peprotech with IL7 neutralizing antibody from R&D Systems.  Cells 
were sorted directly onto the stromal layers and were incubated for 10–14 d at 37 °C 
in 7.5% CO2, followed by flow cytometry. CD11b, Gr1, F4/80 and CD45 were used to 
discern myeloid cells while B220, CD19 and IgM were used for lymphoid cells. 
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